StocksSmith & NephewSN.L

SN.L

Smith & Nephew

1292.34 -10.99 (-0.84%)
Prices By Xignite, in GBX Market Closed
Trade
S
1292.34
B
1295.67

Overview

Prev Close1292.34
Day's Range 1291.34 - 1313.32
52 Week Range 1150.96 - 1599.06
Average Volume (3m)2.22M
1-Year Return-16.12%
Beta-0.052
Market Cap11.29B
P/E Ratio29.79
Revenue3.79B
EPS0.4351
Dividend (Yield)0.2766 (2.14%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.715/12/202125/02/202210/05/20221200.001225.001250.001275.001300.001325.001350.00
Chart times in UTC
Industry Medical Specialties
CEO Deepak S Nath, PhD
Employees 18,369

FINANCIAL SUMMARY

For the quarter ended 31/12/2014, Smith & Nephew's revenues increased by 14.71% and amounted to 788.98M. Net income increased by 65.39% to 101.07M. Net assets increased by 4.57% to 2.59B and EPS increased from 0.07 to 0.11.
SN.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
70.41%
Net Profit Margin
12.23%
Operating Margin
14.66%
Return On Investment
8.79%
03/14
06/14
09/14
12/14
Total Revenue
648.33M
681.44M
687.79M
788.98M
Gross Profit
473.1M
502.02M
492.48M
575.47M
Operating Income
123.86M
133.67M
124.02M
198.35M
Net Income
90.63M
52.88M
61.11M
101.07M